APGE
Price
$39.48
Change
-$0.88 (-2.18%)
Updated
May 23 closing price
Capitalization
2.3B
CABA
Price
$1.75
Change
-$0.03 (-1.69%)
Updated
May 23 closing price
Capitalization
88.8M
75 days until earnings call
Interact to see
Advertisement

APGE vs CABA

Header iconAPGE vs CABA Comparison
Open Charts APGE vs CABABanner chart's image
Apogee Therapeutics
Price$39.48
Change-$0.88 (-2.18%)
Volume$405.97K
Capitalization2.3B
Cabaletta Bio
Price$1.75
Change-$0.03 (-1.69%)
Volume$690.52K
Capitalization88.8M
APGE vs CABA Comparison Chart
Loading...
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APGE vs. CABA commentary
May 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a Buy and CABA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 24, 2025
Stock price -- (APGE: $39.48 vs. CABA: $1.75)
Brand notoriety: APGE and CABA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 62% vs. CABA: 47%
Market capitalization -- APGE: $2.3B vs. CABA: $88.8M
APGE [@Biotechnology] is valued at $2.3B. CABA’s [@Biotechnology] market capitalization is $88.8M. The market cap for tickers in the [@Biotechnology] industry ranges from $298.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whileCABA’s FA Score has 1 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • CABA’s FA Score: 1 green, 4 red.
According to our system of comparison, APGE is a better buy in the long-term than CABA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 6 TA indicator(s) are bullish while CABA’s TA Score has 5 bullish TA indicator(s).

  • APGE’s TA Score: 6 bullish, 3 bearish.
  • CABA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, APGE is a better buy in the short-term than CABA.

Price Growth

APGE (@Biotechnology) experienced а -2.81% price change this week, while CABA (@Biotechnology) price change was -13.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.22%. For the same industry, the average monthly price growth was +3.23%, and the average quarterly price growth was -2.73%.

Reported Earning Dates

APGE is expected to report earnings on May 12, 2025.

CABA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+1.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($2.3B) has a higher market cap than CABA($88.8M). APGE YTD gains are higher at: -12.848 vs. CABA (-22.907). CABA has higher annual earnings (EBITDA): -112.92M vs. APGE (-216.68M). APGE has more cash in the bank: 521M vs. CABA (183M). APGE has less debt than CABA: APGE (11.8M) vs CABA (15.2M). APGE (0) and CABA (0) have equivalent revenues.
APGECABAAPGE / CABA
Capitalization2.3B88.8M2,592%
EBITDA-216.68M-112.92M192%
Gain YTD-12.848-22.90756%
P/E RatioN/AN/A-
Revenue00-
Total Cash521M183M285%
Total Debt11.8M15.2M78%
TECHNICAL ANALYSIS
Technical Analysis
APGECABA
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 3 days ago
86%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 10 days ago
84%
Bullish Trend 9 days ago
88%
Declines
ODDS (%)
Bearish Trend 6 days ago
79%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WHGLY18.050.37
+2.09%
WH Group Ltd.
FSNUY12.510.16
+1.29%
Fresenius SE & Co. KGaA
GMGMF0.46N/A
+0.33%
Graphene Manufacturing Group Ltd.
MQBKY132.850.17
+0.13%
Macquarie Group, Ltd.
FNMAT12.45-0.14
-1.11%
Fannie Mae

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with SYRE. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
-2.18%
SYRE - APGE
53%
Loosely correlated
-0.40%
ELVN - APGE
52%
Loosely correlated
-3.13%
ERAS - APGE
52%
Loosely correlated
N/A
ATXS - APGE
51%
Loosely correlated
N/A
CRNX - APGE
51%
Loosely correlated
-1.16%
More

CABA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CABA has been loosely correlated with KYTX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CABA jumps, then KYTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CABA
1D Price
Change %
CABA100%
-1.69%
KYTX - CABA
46%
Loosely correlated
+2.71%
IMNM - CABA
45%
Loosely correlated
+0.35%
CCCC - CABA
42%
Loosely correlated
+1.47%
ARWR - CABA
42%
Loosely correlated
-1.18%
APGE - CABA
42%
Loosely correlated
-2.18%
More